120 results
SC TO-T/A
EX-99
REGN
Regeneron Pharmaceuticals, Inc.
25 Sep 23
Third party tender offer statement (amended)
8:48am
, portfolio and strengths in research.”
“As we advance Regeneron’s commitment to genetic medicine, we welcome our new colleagues and their important expertise
SC TO-T
EX-99
DBTX
Decibel Therapeutics, Inc.
25 Aug 23
Third party tender offer statement
7:46am
financing commitment in connection with the Merger Agreement or the transactions contemplated thereby.
See Section 9 — “Source and Amount of Funds.”
Is your … Agreement and resulting from the transactions contemplated thereby. Neither Regeneron nor Purchaser has entered into any financing commitment in connection
SC TO-C
EX-99.1
DBTX
Decibel Therapeutics, Inc.
9 Aug 23
Information about tender offer
4:15pm
of Decibel, who have been long-standing collaborators, notable for their deep scientific knowledge and commitment to people with hearing loss,” said
DEFA14A
eddn6u8oy zzw
17 May 23
Additional proxy soliciting materials
4:04pm
8-K
EX-10.1
wq7sy
29 Mar 23
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
w9cy6vgnt4i
29 Mar 23
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
by9f67592js
20 Dec 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-99.1
7jscfmxmhp4
3 Aug 22
Regeneron Reports Second Quarter 2022 Financial and Operating Results
7:08am
SC TO-T/A
EX-99
54k tsbuiriz
31 May 22
Third party tender offer statement (amended)
8:38am
SC TO-T
EX-99
3gvujhbuh7ub32x5q
2 May 22
Third party tender offer statement
7:48am
DEFA14A
2ft1vu6dn j1g3q
21 Apr 22
Additional proxy soliciting materials
4:21pm
SC TO-C
EX-99.1
v7g05cku8m35aoasw2v
19 Apr 22
Information about tender offer
4:50pm
8-K
EX-10.1
rryzwt
8 Mar 22
Entry into a Material Definitive Agreement
6:15am
8-K
EX-10.2
jh09w5e
8 Mar 22
Entry into a Material Definitive Agreement
6:15am